In contrast, Førland et al. (2018) found that CSF α-synuclein levels did not predict longitudinal cognitive decline in executive function memory and visuospatial function after 2–4 years follow-up in PD patients (Table 1E). This evidence concerns the gene SNCA and Parkinson disease.